Exchange: NASDAQ·Updated 04:49 AM EDT
IRD logo

IRD Opus Genetics Inc.

$4.81
$0.21
(4.57%)
Pre-Market
Prev Close $4.60
Reported EarningsAug 6
Mkt Cap$370.22M
Vol12.00

About IRD

Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Durham, NC.
84

Extremely Bullish Sentiment

How do you feel about IRD?

Advertisement|Remove ads.